The rise of Viagra initially drove a surge for pharma, but recent changes present a murky scenario for investors. Off-patent alternatives are eating into revenue, and continued litigation add more complexity to the https://joanoueo484712.goabroadblog.com/39951865/viagra-and-big-pharma-a-precarious-play